Showing results (51-60 of 125) with videos related to

Sort By:
Pageof 13
Antimicrobial Agents and Chemotherapy|October 25, 2003
In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfacesIssam Raad, Ioannis Chatzinikolaou, Gassan Chaiban, et al.
International Journal of Antimicrobial Agents|December 3, 2014
Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignanciesIssam I Raad, Aline El Zakhem, Gilbert El Helou, et al.
Diagnostic Microbiology and Infectious Disease|May 14, 2003
Aspergillosis caused by non-fumigatus Aspergillus species: risk factors and in vitro susceptibility compared with Aspergillus fumigatusHarrys A Torres, Gustavo A Rivero, Russell E Lewis, et al.
Journal of Fungi (Basel, Switzerland)|January 20, 2022
Real-World Use of Isavuconazole as Primary Therapy for Invasive Fungal Infections in High-Risk Patients with Hematologic Malignancy or Stem Cell TransplantHiba Dagher, Ray Hachem, Anne-Marie Chaftari, et al.
CA: a Cancer Journal for Clinicians|September 23, 2022
Prevention of device-related infections in patients with cancer: Current practice and future horizonsGeorge M Viola, Ariel D Szvalb, Alexandre E Malek, et al.
Antimicrobial Agents and Chemotherapy|June 15, 2016
In Vitro Assessment of the Antimicrobial Efficacy of Optimized Nitroglycerin-Citrate-Ethanol as a Nonantibiotic, Antimicrobial Catheter Lock Solution for Prevention of Central Line-Associated Bloodstream InfectionsRuth A Reitzel, Joel Rosenblatt, Cheryl Hirsh-Ginsberg, et al.
Open Forum Infectious Diseases|October 30, 2019
Impact of Catheter Management on Clinical Outcome in Adult Cancer Patients With Gram-Negative BacteremiaJohny Fares, Melissa Khalil, Anne-Marie Chaftari, et al.
Annals of Medicine|September 20, 2018
Invasive pulmonary aspergillosis in patients with solid tumours: risk factors and predictors of clinical outcomesDima Dandachi, Rita Wilson Dib, Ana Fernández-Cruz, et al.
Infection Control and Hospital Epidemiology|March 1, 2002
Masking of neutropenic patients on transport from hospital rooms is associated with a decrease in nosocomial aspergillosis during constructionIssam Raad, Hend Hanna, Cheryl Osting, et al.
Plos One|June 9, 2017
Gastrointestinal cancer cells treatment with bevacizumab activates a VEGF autoregulatory mechanism involving telomerase catalytic subunit hTERT via PI3K-AKT, HIF-1α and VEGF receptorsNadine Mahfouz, Roula Tahtouh, Nada Alaaeddine, et al.
Pageof 13